Home/BioAxone Biosciences/Cathy Sohn, Pharm.D.

CS

Cathy Sohn, Pharm.D.

Business Advisor

BioAxone Biosciences

Therapeutic Areas

Neurology Neurovascular

BioAxone Biosciences Pipeline

Drug	Indication	Phase
Spinal Cord Injury Program	Spinal Cord Injury	Clinical
Cerebral Cavernous Malformation Program	Cerebral Cavernous Malformation (CCM)	Clinical

Leadership Team at BioAxone Biosciences

Lisa McKerracher, Ph.D.

Chief Executive Officer

Pierre Caouette

Chief Operating Officer & Co-Founder

Krista McKerracher, MBA

Business Advisor

View full BioAxone Biosciences profile